The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries.

by Steven G Morgan, Brandon Yau, Murray M Lumpkin
Published 2017-01-01

The COVID‐19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics

by Uttara Soumyanarayanan, Mimi Choong, James Leong, Murray M. Lumpkin, Guido Rasi, John H. Skerritt, Silke Vogel, John C. W. Lim
Published 2021-05-01